摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

14-hydroxycodeinone trifluorocarbonate

中文名称
——
中文别名
——
英文名称
14-hydroxycodeinone trifluorocarbonate
英文别名
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;2,2,2-trifluoroacetic acid
14-hydroxycodeinone trifluorocarbonate化学式
CAS
——
化学式
C2HF3O2*C18H19NO4
mdl
——
分子量
427.377
InChiKey
NJRWSLDEBSUWLL-RKXJKUSZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.46
  • 重原子数:
    30
  • 可旋转键数:
    1
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    96.3
  • 氢给体数:
    2
  • 氢受体数:
    10

反应信息

  • 作为产物:
    描述:
    蒂巴因氧气 、 tetraphenylporphyrin 作用下, 以 二氯甲烷三氟乙酸 为溶剂, 以61%的产率得到14-hydroxycodeinone trifluorocarbonate
    参考文献:
    名称:
    Photooxidation of thebaine. A route to 14-hydroxymorphinones and hydrodibenzofuran analogs of methadone
    摘要:
    The photooxidation of thebaine (1) produces a highly functionalized hydrodibenzofuran 2 via formation of the endoperoxide and a tert-amine radical cation. Photooxidation of the quaternary ammonium salt of thebaine 6, allows the isolation of the endoperoxide 7. Photooxidation of thebaine 1 in acidic medium (TFA), yields 14-hydroxycodeinone salt 3 via the corresponding endoperoxide.
    DOI:
    10.1016/s0040-4039(00)77290-x
点击查看最新优质反应信息

文献信息

  • [EN] PROCESS FOR IMPROVED OPIOID SYNTHESIS<br/>[FR] PROCÉDÉ POUR AMÉLIORER LA SYNTHÈSE D'OPIOÏDES
    申请人:RHODES TECHNOLOGIES
    公开号:WO2014013311A1
    公开(公告)日:2014-01-23
    Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxycodone base and/or an oxycodone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.
    用于制备阿片类药物的起始物或中间物的化合物和组合物,例如,羟考酮基和/或羟考酮盐;制备这些化合物和组合物的过程;这些化合物和组合物在制备活性药物成分和制药剂量形式中的用途;以及这些活性药物成分和制药剂量形式在治疗医疗状况中的用途。
  • [EN] PROCESS FOR IMPROVED OXYCODONE SYNTHESIS<br/>[FR] PROCÉDÉ POUR UNE MEILLEURE SYNTHÈSE DE L'OXYCODONE
    申请人:RHODES TECHNOLOGIES
    公开号:WO2015107471A1
    公开(公告)日:2015-07-23
    Processes for preparing oxycodone are provided. Said processes encompass a step which is a hydrogenation of an 14-hydroxycodeinone salt in the presence of trifluoroacetic acid and/or a glycol.
    提供了制备羟考酮的过程。所述过程包括在三氟乙酸和/或乙二醇存在下对14-羟基可待因盐进行氢化的步骤。
  • PROCESS FOR IMPROVED OXYCODONE SYNTHESIS
    申请人:RHODES TECHNOLOGIES
    公开号:US20170022210A1
    公开(公告)日:2017-01-26
    Processes for preparing oxycodone are provided. Said processes encompass a step which is a hydrogenation of an 14-hydroxycodeinone salt in the presence of trifluoroacetic acid and/or a glycol.
    提供了制备羟考酮的工艺。所述工艺包括在三氟乙酸和/或乙二醇存在下对14-羟基可待因酮盐进行氢化的步骤。
  • PROCESS FOR IMPROVED OPIOID SYNTHESIS
    申请人:RHODES TECHNOLOGIES
    公开号:US20150259355A1
    公开(公告)日:2015-09-17
    Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxycodone base and/or an oxycodone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.
    化合物和组合物可用作阿片类药物的起始物质或中间物质,包括例如盐酸氧考酮或氧考酮基础物质; 制备这些化合物和组合物的过程; 在制备活性药物成分和制药剂型中使用这些化合物和组合物; 以及使用该活性药物成分和制药剂型治疗医学疾病的用途。
  • Process for improved opioid synthesis
    申请人:RHODES TECHNOLOGIES
    公开号:US10202396B2
    公开(公告)日:2019-02-12
    Compounds and compositions for use as starting materials or intermediate materials in the preparation of opioids including, e.g., oxycodone base and/or an oxycodone salt; processes for preparing these compounds and compositions; uses of these compounds and compositions in the preparation of APIs and pharmaceutical dosage forms; and uses of said APIs and pharmaceutical dosage forms in the treatment of medical conditions.
    在制备阿片类药物中用作起始原料或中间原料的化合物和组合物,包括羟考酮碱和/或羟考酮盐;制备这些化合物和组合物的工艺;这些化合物和组合物在制备原料药和药物剂型中的用途;以及上述原料药和药物剂型在治疗疾病中的用途。
查看更多